VC005 not checked

Jiangsu vcare pharmaceutical technology co., LTD

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
9 active
21 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“A single dose of metformin was administered in the period 1. and a single dose of metformin and VC005 coadministration in the period 2”In the company’s words, NCT07796191 on ClinicalTrials.gov
Tested for
Atopic Dermatitis (2 trials), Non-segmental Vitiligo (2 trials), Alopecia Areata (2 trials), Active Ankylosing Spondylitis, Moderate to Severe Atopic Dermatitis
Main trialPhase 3
“This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.”In the company’s words, NCT07172360 on ClinicalTrials.gov

Other drugs for Atopic Dermatitis

All 90 drugs for Atopic Dermatitis

Coming up9

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials21

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 30 Aug 2027 Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Phase 3Recruiting 30 Aug 2027 Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Phase 3Recruiting 30 May 2028 Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis
Phase 2Recruiting 22 Feb 2027 A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis
Phase 2Recruiting 30 Aug 2027 Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo
Phase 2Recruiting 30 Dec 2028 Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata
Phase 1/2Not yet recruiting 30 May 2027 A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo
Phase 1Not yet recruiting 30 Nov 2026 Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects
Phase 1Recruiting 30 Dec 2027 A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata
Phase 2Completed 11 May 2024 Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Phase 2Completed 9 Jul 2024 Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis
Phase 2Completed 31 Oct 2025 Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis
Phase 1Completed 26 Aug 2022 Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
Phase 1Completed 2 Nov 2022 Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
Phase 1Completed 18 Oct 2023 A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
Phase 1Completed 23 May 2024 Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis
Phase 1Completed 3 Jun 2025 The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers
Phase 1Completed 6 Feb 2026 Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis
Phase 1Completed 30 Apr 2026 A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.
Phase 1Completed 2 Aug 2026 Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function
Phase 1Completed 2 Aug 2026 Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow VC005

Following is part of Solo: you see every change to VC005 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in